WallStreetZenWallStreetZen

AnalystsDana Flanders
Dana Flanders's Stock Forecasts

Analyst Ranking
Bottom 10%
#4132 out of 4560 analysts
Average Return
-36.1%
Win Rate
11%1 out of 9
Risk vs Reward
Poor
Good

Dana Flanders's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Aerie Pharmaceuticals IncAERI
+18.49%$11.95$14.16
2020-09-08 -
2021-09-07
Strong Buy

Dana Flanders Analyst Color

Get additional color on Dana Flanders's coverage of popular stocks

Dana Flanders's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Impel Pharmaceuticals IncIMPLQ
1Strong Buy$32.00N/AInitiates Coverage On
3 years ago
Scynexis IncSCYX
1Strong Buy$25.00N/AInitiates Coverage On
3 years ago
Trevena IncTRVN
1Strong Buy$125.00N/AInitiates Coverage On
4 years ago
Aerie Pharmaceuticals IncAERI
1Strong Buy$20.00N/AInitiates Coverage On
4 years ago
Pacira Biosciences IncPCRX
1HoldN/AN/AInitiates Coverage On
4 years ago
Heron Therapeutics IncHRTX
1Strong Buy$24.00N/AInitiates Coverage On
4 years ago
Flexion Therapeutics IncFLXN
1Strong Buy$20.00N/AInitiates Coverage On
4 years ago
Collegium Pharmaceutical IncCOLL
1HoldN/AN/AInitiates Coverage On
4 years ago
Ligand Pharmaceuticals IncLGND
2HoldN/AN/AInitiates Coverage On
4 years ago
Emergent Biosolutions IncEBS
1Strong Buy$75.00N/AUpgrades
5 years ago
Myovant Sciences LtdMYOV
1Hold$25.00N/AInitiates Coverage On
5 years ago
Endo International PLCENDPQ
2Hold$15.00N/AUpgrades
6 years ago
Portola Pharmaceuticals IncPTLA
1Strong Buy$75.00N/AInitiates Coverage On
6 years ago
Momenta Pharmaceuticals IncMNTA
1Hold$18.00N/AInitiates Coverage On
7 years ago
Impax Laboratories IncIPXL
1Hold$20.00N/AInitiates Coverage On
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.